全球特種仿製藥注射劑市場規模:按類型(製藥、生物製藥)、按應用(腫瘤、心血管、傳染病、中樞神經系統、自身免疫性疾病等)、按地區預測(2022-2028 年)
市場調查報告書
商品編碼
1090028

全球特種仿製藥注射劑市場規模:按類型(製藥、生物製藥)、按應用(腫瘤、心血管、傳染病、中樞神經系統、自身免疫性疾病等)、按地區預測(2022-2028 年)

Global Specialty Injectable Generics Market Size study, by Type (Drugs, Biologics), by Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others) and Regional Forecasts 2022-2028

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

特殊仿製藥注射劑的全球市場比傳統藥物便宜,專利到期數量不斷增加,新產品上市,疾病流行。有增加的趨勢。

另一方面,製造生物製藥和仿製藥注射劑是一項昂貴且艱鉅的任務,可能會在預測期內阻礙市場的增長。

本報告調查了全球仿製藥注射劑市場,並提供了包括市場概況、市場分析、類型/用途/區域分析和競爭格局在內的全面資訊。

目錄

第 1 章執行摘要

第 2 章全球特殊仿製藥注射劑市場的定義和範圍

第 3 章全球特殊仿製藥注射劑市場動態

  • 特殊仿製藥注射劑市場影響分析(2020-2028)

第 4 章全球特種注射劑市場:行業分析

  • 波特五力模型
  • PEST 分析
  • 投資採用模式
  • 分析師建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估:COVID-19 的影響

    • 評估 COVID-19 對行業的整體影響
    • COVID-19 前後的市場情景

第 6 章世界特殊仿製藥注射劑市場:按類型

  • 市場快照
  • 按類型潛力分析的全球特種通用注射劑市場表現
  • 按類型分列的全球仿製藥注射劑市場估計和預測(2018-2028 年)
  • 特殊仿製藥注射劑市場、細分市場分析
    • 製藥
    • 生物製藥

第 7 章全球特種仿製藥注射劑市場:按應用分類

  • 市場快照
  • 應用潛力分析的特種仿製藥注射劑的全球市場表現
  • 按應用分列的全球仿製藥注射劑市場估計和預測(2018-2028)
  • 特殊仿製藥注射劑市場、細分市場分析
    • 腫瘤
    • 心血管
    • 傳染病
    • 中樞神經系統
    • 自身免疫性疾病
    • 其他

第 8 章全球仿製藥市場:按地區

  • 區域市場概況
  • 北美
    • 美國
    • 加拿大
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他領域

第 9 章競爭資訊

  • 主要市場策略
  • 公司簡介
    • Baxter
    • Cipla Inc.
    • Dr. Reddy's Laboratories Ltd
    • Fresenius Kabi
    • Hikma Pharmaceuticals PLC
    • Novartis AG
    • Par Pharmaceutical
    • Pfizer Inc
    • SAGENT Pharmaceuticals
    • Sun Pharmaceutical Industries Ltd.

第 10 章調查過程

Global Specialty Injectable Generics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Specialty Injectable Generics are drug therapies used for the treatment of chronic conditions that need injection, infusion, or inhalation and are sold as generics.. It includes biologics used in the treatment of a variety of drugs and has the same active ingredients as branded versions, although the inactive contents of the medications can vary. Specialty Injectable Generics are less expensive as compared to traditional drugs and growing number of patents set to expire have led to the adoption of Specialty Injectable Generics across the forecast period. For Instance: as per Statista in 2021, the global specialty generics market was valued at roughly 45 billion dollars in 2018, and it is predicted to grow to nearly 90 billion dollars by 2024. Due to patent expiration, the industry is anticipated to lose 19 billion dollars in prescription medicine sales worldwide by 2022. Following the expiration of a patent, other businesses are permitted to produce less expensive generic versions of the original branded drug. Also, as the key market participants are launching new products and illness prevalence is on the rise are likely to increase the market growth during the forecast period. However, manufacturing biologics and generic injectable is an expensive and difficult operation that may impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Specialty Injectable Generics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of patents set to expire. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as key market participants launching new products and rising illness prevalence would create lucrative growth prospects for the Specialty Injectable Generics Market across Asia-Pacific region.

Major Market players included in this report are:

Baxter

Cipla Inc.

Dr. Reddy's Laboratories Ltd

Fresenius Kabi

Hikma Pharmaceuticals PLC

Novartis AG

Par Pharmaceutical

Pfizer Inc

SAGENT Pharmaceuticals

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define Market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Market. Additionally, the report shall also incorporate available opportunities in micro Markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the Market are explained below:

By Type:

Drugs

Biologics

By Application:

Oncology

Cardiovascular

Infectious Diseases

Central Nervous Systems

Autoimmune Disorders

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Specialty Injectable Generics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Specialty Injectable Generics Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Specialty Injectable Generics Market, by Type, 2020-2028 (USD Billion)
    • 1.2.3. Specialty Injectable Generics Market, by Application, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Specialty Injectable Generics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Specialty Injectable Generics Market Dynamics

  • 3.1. Specialty Injectable Generics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Less expensive as compared to traditional drugs
      • 3.1.1.2. Growing number of patents are set to expire
    • 3.1.2. Market Challenges
      • 3.1.2.1. Manufacturing biologics and generic injectables is an expensive and difficult operation
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Key Market participants are launching new products
      • 3.1.3.2. Illness prevalence is on the rise

Chapter 4. Global Specialty Injectable Generics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Specialty Injectable Generics Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Specialty Injectable Generics Market by Type, Performance - Potential Analysis
  • 6.3. Global Specialty Injectable Generics Market Estimates & Forecasts by Type, 2018-2028 (USD Billion)
  • 6.4. Specialty Injectable Generics Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. Biologics

Chapter 7. Global Specialty Injectable Generics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Specialty Injectable Generics Market by Application, Performance - Potential Analysis
  • 7.3. Global Specialty Injectable Generics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
  • 7.4. Specialty Injectable Generics Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. Cardiovascular
    • 7.4.3. Infectious Diseases
    • 7.4.4. Central Nervous Systems
    • 7.4.5. Autoimmune Disorders
    • 7.4.6. Others

Chapter 8. Global Specialty Injectable Generics Market, Regional Analysis

  • 8.1. Specialty Injectable Generics Market, Regional Market Snapshot
  • 8.2. North America Specialty Injectable Generics Market
    • 8.2.1. U.S. Specialty Injectable Generics Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Application breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Specialty Injectable Generics Market
  • 8.3. Europe Specialty Injectable Generics Market Snapshot
    • 8.3.1. U.K. Specialty Injectable Generics Market
    • 8.3.2. Germany Specialty Injectable Generics Market
    • 8.3.3. France Specialty Injectable Generics Market
    • 8.3.4. Spain Specialty Injectable Generics Market
    • 8.3.5. Italy Specialty Injectable Generics Market
    • 8.3.6. Rest of Europe Specialty Injectable Generics Market
  • 8.4. Asia-Pacific Specialty Injectable Generics Market Snapshot
    • 8.4.1. China Specialty Injectable Generics Market
    • 8.4.2. India Specialty Injectable Generics Market
    • 8.4.3. Japan Specialty Injectable Generics Market
    • 8.4.4. Australia Specialty Injectable Generics Market
    • 8.4.5. South Korea Specialty Injectable Generics Market
    • 8.4.6. Rest of Asia Pacific Specialty Injectable Generics Market
  • 8.5. Latin America Specialty Injectable Generics Market Snapshot
    • 8.5.1. Brazil Specialty Injectable Generics Market
    • 8.5.2. Mexico Specialty Injectable Generics Market
  • 8.6. Rest of The World Specialty Injectable Generics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Baxter
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Cipla Inc.
    • 9.2.3. Dr. Reddy's Laboratories Ltd
    • 9.2.4. Fresenius Kabi
    • 9.2.5. Hikma Pharmaceuticals PLC
    • 9.2.6. Novartis AG
    • 9.2.7. Par Pharmaceutical
    • 9.2.8. Pfizer Inc
    • 9.2.9. SAGENT Pharmaceuticals
    • 9.2.10. Sun Pharmaceutical Industries Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Specialty Injectable Generics Market, report scope
  • TABLE 2. Global Specialty Injectable Generics Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Specialty Injectable Generics Market estimates & forecasts by Type 2018-2028 (USD Billion)
  • TABLE 4. Global Specialty Injectable Generics Market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 6. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. U.S. Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 17. U.S. Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. Canada Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 19. Canada Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 20. Canada Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. UK Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 22. UK Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 23. UK Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. Germany Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 25. Germany Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 26. Germany Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. RoE Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 28. RoE Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 29. RoE Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. China Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 31. China Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 32. China Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. India Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 34. India Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 35. India Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. Japan Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 37. Japan Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 38. Japan Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. RoAPAC Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. Brazil Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 43. Brazil Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 44. Brazil Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Mexico Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 46. Mexico Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 47. Mexico Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. RoLA Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 49. RoLA Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 50. RoLA Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. Row Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 52. Row Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 53. Row Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of Global Specialty Injectable Generics Market
  • TABLE 55. List of primary sources, used in the study of Global Specialty Injectable Generics Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Specialty Injectable Generics Market, research methodology
  • FIG 2. Global Specialty Injectable Generics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Specialty Injectable Generics Market, key trends 2021
  • FIG 5. Global Specialty Injectable Generics Market, growth prospects 2022-2028
  • FIG 6. Global Specialty Injectable Generics Market, porters 5 force model
  • FIG 7. Global Specialty Injectable Generics Market, pest analysis
  • FIG 8. Global Specialty Injectable Generics Market, value chain analysis
  • FIG 9. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Specialty Injectable Generics Market, regional snapshot 2018 & 2028
  • FIG 15. North America Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia Pacific Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Specialty Injectable Generics Market, company Market share analysis (2021)